Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors


Protein Mutations May Predict Outcomes for GIST Patients Treated with Gleevec® (May 23, 2005)

Protein Mutations May Predict Outcomes for GIST Patients Treated with Gleevec® During a recent presentation at the 2005 annual meeting of the American Society of Clinical Oncology, researchers reported... Continue Reading

SU11248 Effective in Gastrointestinal Stromal Tumors (GIST) (February 16, 2005)

SU11248 Effective in Gastrointestinal Stromal Tumors (GIST) According to results from a recent clinical trial, the multi-targeted agent SI11248 is effective in the treatment of gastrointestinal stromal... Continue Reading

Increased Doses of Gleevec® More Effective in Gastrointestinal Stromal Tumors (September 29, 2004)

Increased Doses of Gleevec® More Effective in Gastrointestinal Stromal Tumors According to a recent article published in the Lancet, increasing the dose of Gleevec® (imatinib mesylate) reduces the risk... Continue Reading

Imatinib Improves Survival in GISTs (February 12, 2002)

Imatinib Improves Survival in GISTs According to a recent article published in The Lancet, imatinib (formerly STI-571) is well tolerated and significantly improves survival in patients with advanced... Continue Reading

« Previous Page

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS